The Journal of Nuclear Medicine; January 2005, Vol 46, Issue 1, supplement

Clinical Practice of Molecular Radiotherapy

Steven M. Larson and Eric P. Krenning

A Pragmatic Perspective on Molecular Targeted Radionuclide Therapy

J Nucl Med 2005 46: 1S-3S.

Amin I. Kassis and S. James Adelstein

Radiobiologic Principles in Radionuclide Therapy

J Nucl Med 2005 46: 4S-12S.

Marion de Jong, Wout A.P. Breeman, Roelf Valkema, Bert F. Bernard, and Eric P. Krenning

Combination Radionuclide Therapy Using 177Lu- and 90Y-Labeled Somatostatin Analogs

J Nucl Med 2005 46: 13S-17S.

George Sgouros

Dosimetry of Internal Emitters

J Nucl Med 2005 46: 18S-27S.

Richard J. Robbins and Martin J. Schlumberger

The Evolving Role of 131I for the Treatment of Differentiated Thyroid Carcinoma

J Nucl Med 2005 46: 28S-37S.

Val J. Lewington

Bone-Seeking Radionuclides For Therapy

J Nucl Med 2005 46: 38S-47S.

Peter Schneider, Jamshid Farahati, and Christoph Reiners

Radiosynovectomy in Rheumatology, Orthopedics, and Hemophilia

J Nucl Med 2005 46: 48S-54S.

Farzana D. Pashankar, M. Sue O'Dorisio, and Yusuf Menda

MIBG and Somatostatin Receptor Analogs in Children: Current Concepts on Diagnostic and Therapeutic Use

J Nucl Med 2005 46: 55S-61S.

Dik J. Kwekkeboom, Jan Mueller-Brand, Giovanni Paganelli, Lowell B. Anthony, Stanislas Pauwels, Larry K. Kvols, Thomas M. O'Dorisio, Roelf Valkema, Lisa Bodei, Marco Chinol, Helmut R. Maecke, and Eric P. Krenning

Overview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin Analogs

J Nucl Med 2005 46: 62S-66S.

Jean Claude Reubi, Helmut R. Mäcke, and Eric P. Krenning

Candidates for Peptide Receptor Radiotherapy Today and in the Future

J Nucl Med 2005 46: 67S-75S.

Eric P. Krenning, Roelf Valkema, Dik J. Kwekkeboom, Wouter W. de Herder, Casper H.J. van Eijck, Marion de Jong, Stanislas Pauwels, and Jean-Claude Reubi

Molecular Imaging as In Vivo Molecular Pathology for Gastroenteropancreatic Neuroendocrine Tumors: Implications for Follow-Up After Therapy

J Nucl Med 2005 46: 76S-82S.

Roelf Valkema, Stanislas A. Pauwels, Larry K. Kvols, Dik J. Kwekkeboom, Francois Jamar, Marion de Jong, Raffaella Barone, Stephan Walrand, Peter P.M. Kooij, Willem H. Bakker, Janet Lasher, and Eric P. Krenning

Long-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with 90Y-DOTA0,Tyr3-Octreotide and 177Lu-DOTA0, Tyr3-Octreotate

J Nucl Med 2005 46: 83S-91S.

Stanislas Pauwels, Raffaella Barone, Stéphan Walrand, Françoise Borson-Chazot, Roelf Valkema, Larry K. Kvols, Eric P. Krenning, and François Jamar

Practical Dosimetry of Peptide Receptor Radionuclide Therapy with 90Y-Labeled Somatostatin Analogs

J Nucl Med 2005 46: 92S-98S.

Raffaella Barone, Françoise Borson-Chazot, Roelf Valkema, Stéphan Walrand, Franck Chauvin, Lida Gogou, Larry K. Kvols, Eric P. Krenning, François Jamar, and Stanislas Pauwels

Patient-Specific Dosimetry in Predicting Renal Toxicity with 90Y-DOTATOC: Relevance of Kidney Volume and Dose Rate in Finding a Dose-Effect Relationship

J Nucl Med 2005 46: 99S-106S.

Jaap J.M. Teunissen, Dik J. Kwekkeboom, Peter P.M. Kooij, Willem H. Bakker, and Eric P. Krenning

Peptide Receptor Radionuclide Therapy for Non-Radioiodine-Avid Differentiated Thyroid Carcinoma

J Nucl Med 2005 46: 107S-114S.

Robert M. Sharkey and David M. Goldenberg

Perspectives on Cancer Therapy with Radiolabeled Monoclonal Antibodies

J Nucl Med 2005 46: 115S-127S.

Richard L. Wahl

Tositumomab and 131I Therapy in Non-Hodgkin's Lymphoma

J Nucl Med 2005 46: 128S-140S.

Yuliya S. Jhanwar and Chaitanya Divgi

Current Status of Therapy of Solid Tumors

J Nucl Med 2005 46: 141S-150S.

Michael R. Zalutsky

Current Status of Therapy of Solid Tumors: Brain Tumor Therapy

J Nucl Med 2005 46: 151S-156S.

Shakeel Modak and Nai-Kong V. Cheung

Antibody-Based Targeted Radiation to Pediatric Tumors

J Nucl Med 2005 46: 157S-163S.

Iris Verel, Gerard W.M. Visser, and Guus A. van Dongen

The Promise of Immuno-PET in Radioimmunotherapy

J Nucl Med 2005 46: 164S-171S.

Helmut R. Maecke, Michael Hofmann, and Uwe Haberkorn

68Ga-Labeled Peptides in Tumor Imaging

J Nucl Med 2005 46: 172S-178S.

Donald J. Buchsbaum, Tandra R. Chaudhuri, and Kurt R. Zinn

Radiotargeted Gene Therapy

J Nucl Med 2005 46: 179S-186S.

Larry K. Kvols

Radiation Sensitizers: A Selective Review of Molecules Targeting DNA and non-DNA Targets

J Nucl Med 2005 46: 187S-190S.

Leo J. Hofland, Astrid Capello, Eric P. Krenning, Marion de Jong, and Martin P. van Hagen

Induction of Apoptosis with Hybrids of Arg-Gly-Asp Molecules and Peptides and Antimitotic Effects of Hybrids of Cytostatic Drugs and Peptides

J Nucl Med 2005 46: 191S-198S.

Deborah A. Mulford, David A. Scheinberg, and Joseph G. Jurcic

The Promise of Targeted -Particle Therapy

J Nucl Med 2005 46: 199S-204S.

pag. 251:

A review of human anti-globulin antibody (HAGA, HAMA, HACA, HAHA) responses to monoclonal antibodies. Not four letter words.

Mirick G. R., Bradt B. M., Denardo S. J., Denardo G. L.

pag. 258 :

Design and manufacture of monoclonal antibodies for radioimmunotherapy

Hale G., Berrie E., Bird P.

pag. 267:

Targeting the bone marrow: applications in stem cell transplantation

Orchard K., Cooper M.

pag. 279:

Engineered single chain antibody fragments for radioimmunotherapy

Huhalov A., Chester K. A.

pag. 289:

Radioimmunotherapy with a-particle emitting radionuclides

Zalutsky M. R., Pozzi O. R.

pag. 297:

Radioimmunotherapy of prostate cancer

Smith-Jones P. M.

pag. 305:

Tositumomab and iodine [131I] tositumomab in the management of follicular lymphoma. An oncologist's view

Davies A. J.

pag. 317:

Radioimmunoimaging. Advances and prospects

Van de Wiele C., Revets H., Mertens N.